Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 1/20 | 0.48 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.48 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | DAO | P14920 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.47 |
| ▸ | DDO | Q99489 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29657968 | 0.82 | AOC3 (0.52) | FLT3CYP2A6AOC3KDM4EDAO | |
| SCHEMBL6654107 | 0.82 | AOC3 (0.52) | FLT3CYP2A6AOC3KDM4EDAO | |
| Benzene SCHEMBL11500406 | 0.80 | NPC1 (0.52) | FLT3CYP2A6AOC3KDM4EDAO | |
| SCHEMBL5598773 | 0.78 | AOC3 (0.48) | FLT3CYP2A6AOC3KDM4EDAO | |
| SCHEMBL30012071 | 0.78 | CHEK1 (0.44) | FLT3CYP2A6AOC3KDM4EDAO | |
| SCHEMBL28406859 | 0.78 | FLT3 (0.44) | FLT3CYP2A6AOC3KDM4EDAO | |
| SCHEMBL11366274 | 0.78 | CHEK1 (0.44) | FLT3CYP2A6AOC3KDM4EDAO | |
| SCHEMBL5173283 | 0.75 | FLT3 (0.46) | FLT3CYP2A6AOC3KDM4EDAO | |
| SCHEMBL1002265 | 0.75 | AOC3 (0.45) | FLT3CYP2A6AOC3KDM4EDAO | |
| SCHEMBL1002262 | 0.75 | AOC3 (0.45) | FLT3CYP2A6AOC3KDM4EDAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118702611-A | Nitrosoindole alkaloid compound in purslane, and extraction and separation method and application thereof | 辽宁中医药大学 | 2024-09-27 | — | — | CN | claimed |
| CN-111662299-B | Substituted indolocazazepine compound and preparation method and application thereof | 中山大学 | 2022-07-26 | — | — | CN | claimed |
| US-20030119016-A1 | Antisense oligonucleotides with increased RNase sensitivity | THIRD WAVE TECHNOLOGIES, INC. | 2003-06-26 | — | — | US | claimed |
| US-4314058-A | Indolins styryl-like compounds | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1982-02-02 | — | — | US | claimed |
| CN-118702611-B | Nitrosoindole alkaloid compound in purslane, and extraction and separation method and application thereof | 辽宁中医药大学 | 2025-09-05 | — | — | CN | disclosed |
| CN-118702611-B | Nitrosoindole alkaloid compound in purslane, and extraction and separation method and application thereof | 辽宁中医药大学 | 2025-09-05 | — | — | CN | disclosed |
| CN-118702611-A | Nitrosoindole alkaloid compound in purslane, and extraction and separation method and application thereof | 辽宁中医药大学 | 2024-09-27 | — | — | CN | disclosed |
| CN-118702611-A | Nitrosoindole alkaloid compound in purslane, and extraction and separation method and application thereof | 辽宁中医药大学 | 2024-09-27 | — | — | CN | disclosed |
| CN-118702611-A | Nitrosoindole alkaloid compound in purslane, and extraction and separation method and application thereof | 辽宁中医药大学 | 2024-09-27 | — | — | CN | disclosed |
| US-11370757-B2 | Photocleavable nitroindoline-based crosslinkers | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-06-28 | — | — | US | disclosed |
| US-7790877-B2 | Antisense oligonucleotides with increased RNase sensitivity | GEN-PROBE, INCORPORATED (US) | 2010-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030119016-A1 | Antisense oligonucleotides with increased RNase sensitivity | RNASE1, RNASEL, RNASEH1 | FLT3 4426/4885CYP2A6 3822/4885AOC3 2175/4885 |
| US-11370757-B2 | Photocleavable nitroindoline-based crosslinkers | OTUD7B, ALAD, NNMT | FLT3 4579/4885CYP2A6 1050/4885AOC3 644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.